nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.0732	0.0774	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—MYLK—malignant glioma	0.0669	0.0707	CbGpPWpGaD
Sulfisoxazole—EDNRA—EGFR-dependent Endothelin signaling events—EGF—malignant glioma	0.0553	0.0584	CbGpPWpGaD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—PTGS1—malignant glioma	0.0423	0.0447	CbGpPWpGaD
Sulfisoxazole—CYP2C9—CYP2E1 reactions—CYP2B6—malignant glioma	0.0309	0.0327	CbGpPWpGaD
Sulfisoxazole—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—malignant glioma	0.0301	0.0318	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—CCR4—malignant glioma	0.0271	0.0286	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.0225	0.0238	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.0216	0.0228	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—CXCR3—malignant glioma	0.0201	0.0213	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.0191	0.0202	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—BDKRB2—malignant glioma	0.0184	0.0195	CbGpPWpGaD
Sulfisoxazole—Sulfaphenazole—CYP2B6—malignant glioma	0.0173	0.319	CrCbGaD
Sulfisoxazole—EDNRA—GPCRs, Other—CXCR3—malignant glioma	0.0171	0.018	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.0166	0.0175	CbGpPWpGaD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.0162	0.0171	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—RAF1—malignant glioma	0.0155	0.0164	CbGpPWpGaD
Sulfisoxazole—Dapsone—CYP2C18—malignant glioma	0.0154	0.285	CrCbGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.0131	0.0139	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCR4—malignant glioma	0.0127	0.0135	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0125	0.0132	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.00998	0.0105	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—PTGS1—malignant glioma	0.00961	0.178	CrCbGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CXCR3—malignant glioma	0.00947	0.01	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—RAF1—malignant glioma	0.00925	0.00978	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—BDKRB2—malignant glioma	0.00877	0.00927	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—BDKRB2—malignant glioma	0.00866	0.00916	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00855	0.00904	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—KNG1—malignant glioma	0.00798	0.00844	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00795	0.00841	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—KNG1—malignant glioma	0.00788	0.00833	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00785	0.00829	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00785	0.00829	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS1—malignant glioma	0.00752	0.139	CrCbGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00741	0.00784	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00714	0.00755	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00689	0.00729	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.0068	0.00719	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00678	0.00717	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCR4—malignant glioma	0.00651	0.00688	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00645	0.00681	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00635	0.00672	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00632	0.00669	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00604	0.00639	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00581	0.00614	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00559	0.00591	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LATS2—malignant glioma	0.00556	0.00588	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00529	0.00559	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—F2—malignant glioma	0.00516	0.00545	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—F2—malignant glioma	0.00509	0.00538	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCR3—malignant glioma	0.00484	0.00511	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.00461	0.00488	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—AKT1—malignant glioma	0.0045	0.00475	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—BDKRB2—malignant glioma	0.00442	0.00468	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.00434	0.00459	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS2—malignant glioma	0.0043	0.0795	CrCbGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00424	0.00448	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LATS1—malignant glioma	0.00421	0.00445	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—KNG1—malignant glioma	0.00402	0.00425	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00401	0.00424	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR4—malignant glioma	0.00368	0.00389	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.00359	0.00379	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.00347	0.00366	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.00342	0.00362	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00342	0.00361	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.00338	0.00357	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR4—malignant glioma	0.00334	0.00353	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.00297	0.00314	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.00293	0.0031	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MDK—malignant glioma	0.00285	0.00301	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCR3—malignant glioma	0.00273	0.00289	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DTX1—malignant glioma	0.00272	0.00287	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—F2—malignant glioma	0.0026	0.00275	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—BDKRB2—malignant glioma	0.0025	0.00264	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCR3—malignant glioma	0.00248	0.00262	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00241	0.00254	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.0024	0.00254	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.00238	0.00251	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00232	0.00245	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—PIK3CA—malignant glioma	0.00231	0.00244	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—KNG1—malignant glioma	0.00227	0.0024	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—BDKRB2—malignant glioma	0.00227	0.0024	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.00225	0.00238	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.00224	0.00237	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SUFU—malignant glioma	0.00216	0.00228	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HEY2—malignant glioma	0.00213	0.00225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GFAP—malignant glioma	0.00208	0.0022	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KNG1—malignant glioma	0.00207	0.00218	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.00206	0.00218	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SPHK1—malignant glioma	0.00201	0.00213	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR4—malignant glioma	0.00197	0.00209	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HEY1—malignant glioma	0.00197	0.00209	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIST1H3B—malignant glioma	0.00192	0.00203	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCL8—malignant glioma	0.00183	0.00194	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MMP3—malignant glioma	0.00183	0.00193	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JAG2—malignant glioma	0.00175	0.00185	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—RTEL1—malignant glioma	0.00168	0.00178	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.00166	0.00176	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.00164	0.00174	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—H3F3A—malignant glioma	0.00148	0.00157	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—F2—malignant glioma	0.00147	0.00155	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCR3—malignant glioma	0.00147	0.00155	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—YWHAE—malignant glioma	0.00143	0.00151	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NTRK2—malignant glioma	0.00143	0.00151	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FLT1—malignant glioma	0.00142	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DUSP6—malignant glioma	0.00141	0.00149	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CG—malignant glioma	0.00141	0.00149	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JAG1—malignant glioma	0.0014	0.00148	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH3—malignant glioma	0.00139	0.00147	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FBXW7—malignant glioma	0.00137	0.00145	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BDKRB2—malignant glioma	0.00134	0.00142	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—F2—malignant glioma	0.00134	0.00141	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT2—malignant glioma	0.00129	0.00136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CG—malignant glioma	0.00128	0.00135	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PTPN11—malignant glioma	0.00126	0.00133	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH2—malignant glioma	0.00125	0.00132	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CD—malignant glioma	0.00124	0.00131	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KNG1—malignant glioma	0.00122	0.00129	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.0012	0.00127	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT2—malignant glioma	0.00117	0.00124	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00116	0.00123	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NTRK1—malignant glioma	0.00116	0.00123	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CD—malignant glioma	0.00112	0.00119	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP3—malignant glioma	0.00108	0.00114	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CB—malignant glioma	0.00108	0.00114	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN2B—malignant glioma	0.00107	0.00113	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTK2—malignant glioma	0.00104	0.0011	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL8—malignant glioma	0.00104	0.0011	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HES1—malignant glioma	0.00102	0.00108	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NCOR1—malignant glioma	0.00102	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RAF1—malignant glioma	0.001	0.00106	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—malignant glioma	0.00099	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CB—malignant glioma	0.000979	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFRA—malignant glioma	0.000973	0.00103	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—COX8A—malignant glioma	0.000966	0.00102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SPP1—malignant glioma	0.000945	0.000999	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL8—malignant glioma	0.000941	0.000995	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—malignant glioma	0.000899	0.00095	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TERT—malignant glioma	0.000896	0.000947	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFB—malignant glioma	0.000874	0.000924	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGFR1—malignant glioma	0.00087	0.00092	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000864	0.000913	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIF1A—malignant glioma	0.000857	0.000906	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CAV1—malignant glioma	0.000829	0.000876	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ASMT—malignant glioma	0.000822	0.000869	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KDR—malignant glioma	0.000819	0.000866	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000803	0.000849	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FN1—malignant glioma	0.000789	0.000834	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—F2—malignant glioma	0.000789	0.000834	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BAD—malignant glioma	0.000779	0.000824	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—BCAN—malignant glioma	0.000773	0.000817	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH1—malignant glioma	0.000772	0.000816	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CD80—malignant glioma	0.000756	0.000799	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APC—malignant glioma	0.000755	0.000798	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CG—malignant glioma	0.000755	0.000798	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGF—malignant glioma	0.000746	0.000789	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTPN11—malignant glioma	0.000741	0.000784	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BRAF—malignant glioma	0.000709	0.00075	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT2—malignant glioma	0.000691	0.00073	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EGFR—malignant glioma	0.000688	0.000727	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CD—malignant glioma	0.000663	0.000701	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CA—malignant glioma	0.000657	0.000695	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KRAS—malignant glioma	0.00065	0.000687	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF2—malignant glioma	0.000635	0.000672	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—IDH2—malignant glioma	0.000623	0.000658	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CA—malignant glioma	0.000597	0.000631	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MDM2—malignant glioma	0.000594	0.000628	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RAF1—malignant glioma	0.000592	0.000626	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000587	0.000621	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB2—malignant glioma	0.000586	0.00062	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000586	0.000619	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CB—malignant glioma	0.000578	0.000611	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL8—malignant glioma	0.000556	0.000588	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—malignant glioma	0.000537	0.000568	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—IDH1—malignant glioma	0.000536	0.000566	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—malignant glioma	0.000532	0.000562	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—malignant glioma	0.000531	0.000561	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SPHK1—malignant glioma	0.000518	0.000548	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.000508	0.000537	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP9—malignant glioma	0.000503	0.000531	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTEN—malignant glioma	0.0005	0.000528	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—malignant glioma	0.000488	0.000515	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000479	0.000506	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—malignant glioma	0.000451	0.000477	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT3—malignant glioma	0.000447	0.000472	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000436	0.000461	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000421	0.000445	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MYC—malignant glioma	0.000415	0.000439	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTT1—malignant glioma	0.000411	0.000434	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGFR—malignant glioma	0.000406	0.000429	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS1—malignant glioma	0.000385	0.000407	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KRAS—malignant glioma	0.000384	0.000406	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000383	0.000405	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—BCHE—malignant glioma	0.000358	0.000378	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC5A5—malignant glioma	0.000353	0.000373	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CA—malignant glioma	0.000353	0.000373	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—malignant glioma	0.000341	0.000361	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000334	0.000353	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000331	0.00035	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000289	0.000305	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—malignant glioma	0.000288	0.000304	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—malignant glioma	0.000285	0.000301	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAT—malignant glioma	0.000277	0.000293	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOR1—malignant glioma	0.000262	0.000276	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAV1—malignant glioma	0.000213	0.000225	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000204	0.000215	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CG—malignant glioma	0.000194	0.000205	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARG—malignant glioma	0.000187	0.000198	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CD—malignant glioma	0.000171	0.00018	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CB—malignant glioma	0.000149	0.000157	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—malignant glioma	0.000147	0.000156	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTEN—malignant glioma	0.000129	0.000136	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CA—malignant glioma	9.07e-05	9.59e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—malignant glioma	7.41e-05	7.83e-05	CbGpPWpGaD
